Skip to main content
Premium Trial:

Request an Annual Quote

Japan s Radiological Institute Licenses Rosetta s Resolver

NEW YORK, April 29-Rosetta, a Merck subsidiary, said today that it had licensed its Resolver gene expression analysis system to Japan's National Institute of Radiological Sciences.

 

The company did not reveal financial specifics.

 

Resolver is a bioinformatics system for use with DNA microarrays. It is marketed by Agilent Technologies

 

NIRS will use the Rosetta software for research into radiation therapy of malignancies and radiation-based disease diagnostics.

 

This is Rosetta Biosoftware's first license in Asia Pacific.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.